Oncology

Supporting Oncology Research

Cancer is a leading cause of death worldwide, affecting millions of people each year.

In 2020 the National Institutes of Health (NIH) reported an estimated 19.3 million new cancer cases and taking 17.9 million deaths globally¹. The staggering impact of cancer has led to significant investments in oncology research, with pharmaceutical companies spending over $150 billion annually on research and development to discover new treatments and improve patient outcomes. This substantial financial commitment underscores the urgent need for efficient and precise research methodologies to expedite the development of effective cancer therapies².

Sampled, as the world’s only Global Integrated Analytical Biorepository, offers comprehensive support to oncology researchers across various stages of the research pipeline. By outsourcing key services such as sample storage, microarrays, and sequencing to Sampled, researchers can ensure the integrity and quality of their samples while minimizing risks associated with multiple shipments and handling. Sampled’s facilities are equipped with CAP/CLIA-accredited storage solutions and cutting-edge genomic analysis technologies, including 10X Genomics, Illumina, Olink and PacBio. Enabling efficient storage, retrieval, and high-throughput analysis of biological specimens. Additionally, our expertise in cryogenic storage, comparative analysis, and real-time genomic monitoring during clinical trials enhances the accuracy and reliability of research data, ultimately contributing to the advancement of cancer diagnostics and therapeutics. By leveraging Sampled’s specialized services, oncology researchers can focus on groundbreaking discoveries and accelerate the development of new cancer treatments.